Buxus alkaloid KBA01 targets Valosin-containing protein to inhibit colorectal cancer progression via the p53-Wnt/β-catenin axis
- 17 May 2026
- journal article
- Published by Elsevier in Phytomedicine
- Vol. 157, 158314
Abstract
No abstract availableKeywords
Funding Information
- Kunming University of Science and Technology (KUST-KH2023001Z)
- Yunnan Provincial Science and Technology Department (202402AG050002)
- Yunnan Provincial Science and Technology Department (202301AT070034)
This publication has 34 references indexed in Scilit:
- 2024 VCP International Conference: Exploring multi-disciplinary approaches from basic science of valosin containing protein, an AAA+ ATPase protein, to the therapeutic advancement for VCP-associated multisystem proteinopathyNeurobiology of Disease, 2025
- An immunohistochemical and molecular genetic study of 60 colorectal carcinoma brain metastases in pursuit of predictive biomarkers for cancer therapyHuman Pathology, 2025
- Understanding the complexity of p53 in a new era of tumor suppressionCancer Cell, 2024
- Molecular targets of cisplatin in HeLa cells explored through competitive activity-based protein profiling strategyJournal of Inorganic Biochemistry, 2024
- Green tea-derived theabrownin suppresses human non-small cell lung carcinoma in xenograft model through activation of not only p53 signaling but also MAPK/JNK signaling pathwayJournal of Ethnopharmacology, 2022
- Buxus alkaloid compound destabilizes mutant p53 through inhibition of the HSF1 chaperone axisPhytomedicine, 2020
- Role of Thiol Reactivity for Targeting Mutant p53Cell Chemical Biology, 2018
- DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathwayNature Cell Biology, 2016
- SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axisCell Death & Differentiation, 2011
- The p53QS transactivation-deficient mutant shows stress-specific apoptotic activity and induces embryonic lethalityNature Genetics, 2005